New approaches for treatment HCC are being investigated including microRNAs, Golgi-73 Protein (GP73), Glypican-3 (GPC3), Osteopontin (OPN), and more (Tunissiolli et al., 2017). Here, GOLM1 is linked to hepatocellular carcinoma.